Downloads
Revenue

Description

CSP App介绍
这款App是专为中华医学会病理学分会定制的学会服务和管理信息化手机平台。中国病理学专业人士可通过这款App轻松参会,完成所有学会旗下会议注册、缴费、投稿、预定酒店。更可最快速度浏览学会下属学术活动的视频课件、幻灯片、论文、壁报等海量专业学术内容。在线培训模块正在筹划中。我们谨代表中华医学会病理学分会欢迎每位学术同仁开始探索获取学会服务和资讯的崭新体验!

Screenshots

CSP FAQ

  • Is CSP free?

    Yes, CSP is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is CSP legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does CSP cost?

    CSP is free.

  • What is CSP revenue?

    To get estimated revenue of CSP app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Argentina yet.
Ratings History

CSP Reviews

csp学习真方便

冰冰兵兵夏 on

China

此app非常方便实用,参会听课学习的好帮手!

希望学习到更多新知识!

kfjin on

China

上次参加年会并观看视频,还有视频重放,非常感谢!希望今年也能看到更多的精彩内容,并能有更多的回放,学习到更多知识!!

现在看不了会议视频了

陈皮6668 on

China

无缘无故看不了会议视频

很好的工具

新兰永恒yy on

China

参会时使用很方便,尤其是不能到现场时。疫情期间,线上观看直播是种很棒的学习方式

闪退

Yyllzb on

China

一登陆就闪退,怎么解决呢?

为什么苹果手机不能进行参会注册。

,。ytgvnjdixgv on

China

为什么苹果手机不能进行参会注册。

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

CSP Competitors

Name
CSCO
肿瘤指南者医生端
医院在线-智慧互联网医院医生版
急救绿道
衔接,让拯救更有效率!
39互联网医院医生版
医掌宝
爱病理
上海市同济医护
华夏病理
华夏病理云诊断平台

CSP Installs

Last 30 days

CSP Revenue

Last 30 days

CSP Revenue and Downloads

Gain valuable insights into CSP performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English, Chinese
Recent release
1.2.8 (3 years ago )
Released on
Aug 2, 2019 (5 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.